共 50 条
- [1] Nirsevimab (Beyfortus) for Prevention of Severe RSV Disease in Young Children [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1685): : 145 - 148
- [2] Development of Beyfortus® (nirsevimab) in RSV bronchiolitis [J]. EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2024, (203): : 219 - 221
- [3] Nirsevimab (Beyfortus®) in the prevention of RSV bronchiolitis. Decisions based on scientific evidence [J]. EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2023, (197): : 408 - 413
- [5] Nirsevimab (Beyfortus®), to prevent bronchiolitis [J]. ACTUALITES PHARMACEUTIQUES, 2023, 62 (631): : 10 - 12
- [7] Nirsevimab for Prevention of RSV Hospitalizations in Infants [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (12): : 1152 - 1153
- [8] Recommendations of the Austrian Society for Pediatrics and Adolescent Medicine on Prevention of RSV Infections with Nirsevimab [J]. PAEDIATRIE UND PAEDOLOGIE, 2024,
- [10] Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (26): : 2425 - 2435